Formulary Management of Low Molecular Weight Heparins

Author： Wade W.E.   Martin B.C.   Kotzan J.A.   Spruill W.J.   Chisoholm M.A.   Perri M.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.17, Iss.1, 2000-01, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low molecular weight heparins

By Aguilar O.M.   Kleiman N.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Adverse Skin Reactions to Low Molecular Weight Heparins: Frequency, Management and Prevention

By Wütschert R.   Piletta P.   Bounameaux H.  

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 515-525

Adis International

Access to resources Recommend Favorite

Pulmonary Delivery of Low Molecular Weight Heparins

By Yang Tianzhi   Mustafa Fatima   Bai Shuhua   Ahsan Fakhrul  

Pharmaceutical Research, Vol. 21, Iss. 11, 2004-11 ,pp. : 2009-2016

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and Anticoagulant Activity of Low-Molecular-Weight Heparins

By Stolbushkina P. P.   Bannikova G. E.   Drozd N. N.   Makarov V. A.   Varlamov V. P.   Vikhoreva G. A.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 2, 2004-02 ,pp. : 82-85

Springer Publishing Company

Access to resources Recommend Favorite

Costs and Cost Effectiveness of Low Molecular Weight Heparins and Platelet Glycoprotein IIb/IIIa Inhibitors: In the Management of Acute Coronary Syndromes

By Bosanquet N.  

PharmacoEconomics, Vol. 21, Iss. 16, 2003-01 ,pp. : 1135-1152

Adis International

Access to resources Recommend Favorite